Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate
{{output}}
Background: Drug development in Huntington's disease (HD) is particularly challenging, and only two compounds are approved by the FDA. It is therefore essential to appraise drug development programs in order to understand the rea... ...
